RATIONALE: Cysteinyl leukotrienes (cysLTs) facilitate mucosal type 2 (eosinophilic) immunopathology, especially in aspirin-exacerbated respiratory disease (AERD), by incompletely understood mechanisms. Leukotriene C 4 (LTC 4 ) acts at platelet-and epithelial-associated type 2 cysLT receptors (CysLT 2 R) to modulate eosinophilic airway inflammation. Because platelets constitutively express IL-33 protein, which is essential to the induction of type 2 immunopathology and aspirin sensitivity, we sought to determine whether platelets, activated through CysLT 2 R, cause IL-33-dependent immunopathology. METHODS: Prostaglandin E 2 synthase deficient (Ptges -/-) mice were primed with house dust mite extract, and then were challenged with lysine aspirin (Lys-ASA) for lung function and mediator measurement. Lung IL-5, IL-13, and IL-33 were measured by ELISA. Intrapulmonary platelet recruitment was determined by histological staining and western blotting for CD41.
Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA. RATIONALE: Cysteinyl leukotrienes (cysLTs) facilitate mucosal type 2 (eosinophilic) immunopathology, especially in aspirin-exacerbated respiratory disease (AERD), by incompletely understood mechanisms. Leukotriene C 4 (LTC 4 ) acts at platelet-and epithelial-associated type 2 cysLT receptors (CysLT 2 R) to modulate eosinophilic airway inflammation. Because platelets constitutively express IL-33 protein, which is essential to the induction of type 2 immunopathology and aspirin sensitivity, we sought to determine whether platelets, activated through CysLT 2 R, cause IL-33-dependent immunopathology. METHODS: Prostaglandin E 2 synthase deficient (Ptges -/-) mice were primed with house dust mite extract, and then were challenged with lysine aspirin (Lys-ASA) for lung function and mediator measurement. Lung IL-5, IL-13, and IL-33 were measured by ELISA. Intrapulmonary platelet recruitment was determined by histological staining and western blotting for CD41.
RESULTS: Challenges of AERD-like Ptges
-/-mice with inhaled Lys-ASA elicited LTC 4 synthesis and caused rapid intrapulmonary platelet recruitment, accompanied by rapid increases in lung IL-33, IL-5, and IL-13. Platelet depletion and blockade of CysLT 2 R eliminate all manifestations of Lys-ASA challenges, including mast cell activation, changes in airway resistance, and increases in IL-33, IL-5, and IL-13. CONCLUSIONS: Platelets are essential to the CysLT 2 R-driven type 2 respiratory immunopathology and IL-33-dependent aspirin sensitivity. Antiplatelet medications may be useful to treat AERD and other disorders associated with type 2 immunopathology.
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The effect of muscarinic M3 receptor blockage in development of M2 macrophages in allergic inflammation Shin Ohta, MD, PhD, Megumi Jinno, MD, Akihiko Tanaka, MD, PhD, Tomoki Uno, MD, Yoshitaka Uchida, MD, Ryo Manabe, MD, Hitomi Ida, MD, PhD, Naota Kuwahara, MD, Yosuke Fukuda, MD, PhD, Tomoyuki Kimura, MD, Kukniaki Hirai, MD, Yoshito Miyata, MD, Munehiro Yamaguchi, MD, PhD, Tetsuya Homma, MD, PhD, Fumihiro Yamaguchi, MD, PhD, Yoshio Watanabe, MD, PhD, Shintaro Suzuki, MD, PhD, Tsukasa Ohnishi, MD, PhD, Hironori Sagara, MD, PhD, and Sojiro Kusumoto, MD, PhD; Showa University, Tokyo, Japan. RATIONALE: We have reported that muscarinic M3 receptor antagonist (tiotropium) inhibits the allergic airway inflammation in murine model of asthma. However, the mechanism is still unclear. The purpose of this study is to investigate the effect of muscarinic M3 receptor blockage in development of M2 macrophages in allergic inflammation. METHODS: Balb/c mice were sensitized and challenged with OVA to develop the mouse model of asthma. During the challenge phase, mice were treated with/without tiotropium. Twenty-four hours after the last challenge, lung cells were isolated from the lung. The lung cells were gated by CD68 positive cells, and analyzed the expression of Relm-a and Arginase-1 (M2 macrophage markers) by flow cytometry. Additionally, mouse bone marrow cells derived macrophages (mBMMacs) and also human peripheral blood mononuclear cells (PBMCs) derived macrophages were stimulated with IL-4 and treated with muscarinic M3 receptor antagonist in vitro. RESULTS: The number of total cells and eosinophils, and the levels of cytokines (IL-5 and IL-13) in BALF were significantly decreased in asthma group treated with tiotropium compared to untreated asthma group. The expression of Relm-a and Arginase-1 in macrophages was significantly reduced in asthma group treated with tiotropium compared to untreated asthma group, suggesting that the development of M2 macrophages was inhibited by muscarinic M3 receptor blockage. The blockage of muscarinic M3 receptor in vitro, significantly inhibited the development of M2 macrophages in both mBMMacs and PBMCs derived macrophages. CONCLUSIONS: These results suggest that the blockage of muscarinic M3 receptor inhibits the development of M2 macrophages and prevent the allergic airway inflammation. Harvard Medical School, Boston, MA, 8 Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA. RATIONALE: Type 6 purinergic (P2Y 6 ) receptors are high affinity G protein-coupled receptors (GPCRs) for uridine diphosphate (UDP). We found that P2Y 6 receptor expression during the sensitization phase plays a critical role in preventing sensitization to the allergen. In this study, we sought to identify key steps and cell types response for the protective effect of P2Y 6 receptors. METHODS: p2ry6(flox/flox);rosa26creER/+ and p2ry6(flox/flox);+/+ controls were treated with tamoxifen starting either 10 days before the initial sensitization. The mice were sensitized with an extract from Dermatophagoides farinae (Df) intranasally on days 0 and 1. We examined BAL fluid from P2ry6flox/flox/Cre/+ mice and +/+ controls for Th1 cytokines by alveolar macrophages, as well as the NK cell activation, during the sensitization phase. RESULTS: BAL fluid levels of IL-12p40, expression of IFNg, and M1-cytokine/chemokine transcripts by BAL fluid cells increased sharply in response to 2 sensitizing doses of Df in +/+ but not in P2ry6flox/flox/Cre/+ mice. Alveolar macrophages were the dominant source of P2Y 6 receptordependent IL-12p40 expression, driving IFNg production by NK cells. The IL-12-restored P2ry6flox/flox/Cre/+ mice showed significantly increased expression of IFNg at day2 and decreased BAL fluid eosinophils at day 16, compared to the Df-treated +/+ controls. Antibody depletion of NK cells before sensitization abolished the protective effect of P2Y 6 receptors. CONCLUSIONS: Alveolar macrophages use UDP-P2Y 6 signalling to drive an innate IL-12/NK cell axis that strongly influences the outcome of respiratory allergen exposure.
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